Their findings revealed that mARC2 can hinder the progression of HCC by competing with the tumor suppressor protein p27 for degradation via the same ubiquitin E3 ligase, RNF123 (also known as KPC1) [95]. This evidence concerns the gene RNF123 and hepatocellular carcinoma.